US Stocks

GNRSU Stock Crashes 99.99% on Pink Sheets, May 6 2026

Key Points

GNRSU stock collapsed 99.99% to $0.000001 on May 6, 2026.

Greenrose Holding Company faces negative working capital of -$103.4 million and severe liquidity crisis.

Pink sheets trading reflects delisting from major exchanges due to financial distress.

Meyka AI rates GNRSU as B grade HOLD despite near-zero valuation and bankruptcy risk.

Be the first to rate this article

GNRSU stock has experienced a catastrophic collapse, plummeting 99.99% to just $0.000001 USD as of May 6, 2026. The Greenrose Holding Company Inc., a healthcare sector cannabis producer based in Amityville, New York, now trades on the pink sheets (PNK) exchange with a market cap of just $13. This represents one of the most severe stock declines in recent market history. The company, which went public in February 2020, has seen its value essentially erased. With only 145 shares trading and a previous close of $0.15, investors face an unprecedented situation. Understanding what led to this collapse and what it means for shareholders is critical.

GNRSU Stock Price Collapse: What Happened

The Greenrose Holding Company’s GNRSU stock has suffered an unimaginable decline. From a 52-week high of $0.151, the stock now trades at $0.000001, representing a loss of nearly 100% for investors. The company’s market capitalization has shrunk to just $13, making it essentially worthless on paper.

This extreme devaluation suggests severe operational or financial distress. With 12.85 million shares outstanding, the per-share value has become infinitesimal. Trading volume remains extremely low at just 145 shares, indicating minimal liquidity and investor interest. The pink sheets listing reflects the company’s delisted status from major exchanges.

Financial Metrics and Valuation Concerns

Despite the stock price collapse, GNRSU’s financial metrics present a confusing picture. The company reports an EPS of $3.097 and a PE ratio of 0.00000032, which are mathematically distorted by the near-zero stock price. Key metrics show revenue per share of $1.58 and net income per share of $1.12 on a trailing twelve-month basis.

However, the company faces serious liquidity challenges. The current ratio stands at just 0.21, meaning current liabilities far exceed current assets. Working capital is negative at -$103.4 million, and tangible asset value is -$116.3 million. These red flags indicate the company cannot meet its short-term obligations and has negative tangible equity.

Market Sentiment and Trading Activity

Trading activity for GNRSU stock remains virtually nonexistent. With only 145 shares traded and no average volume data available, the stock is essentially illiquid. The day’s range shows no movement, with both low and high at $0.000001, suggesting no meaningful price discovery.

Liquidation pressures appear severe. The company’s debt-to-equity ratio of 1.57 indicates liabilities exceed shareholder equity. Interest coverage of 4.48x provides minimal cushion for debt service. The enterprise value of $101.4 million dwarfs the market cap of $13, reflecting massive debt burden relative to market valuation. This disconnect suggests potential bankruptcy or restructuring scenarios.

Meyka AI Grade and Investment Outlook

Meyka AI rates GNRSU with a grade of B based on a score of 63.47 out of 100. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating suggests a HOLD recommendation despite the stock’s catastrophic price decline.

However, these grades are not guaranteed and we are not financial advisors. The massive disconnect between the B grade and the stock’s near-zero price suggests the grading model may not fully capture the company’s distressed state. Investors should conduct thorough due diligence before considering any position. Track GNRSU on Meyka for real-time updates on this distressed security.

Final Thoughts

GNRSU stock has collapsed 99.99%, leaving shareholders with nearly worthless positions. The company faces severe financial distress with negative working capital of $103.4 million, minimal trading volume, and negative tangible assets. Trading on pink sheets signals deterioration. Despite a B grade from Meyka AI, recovery appears unlikely without major restructuring or capital infusion. Investors should seek professional advice immediately. This case demonstrates the extreme risks of penny stocks and distressed securities in the cannabis industry.

FAQs

Why did GNRSU stock fall 99.99%?

GNRSU collapsed due to severe financial distress, negative working capital of -$103.4 million, and inability to meet obligations. The company’s shift to pink sheets reflects delisting from major exchanges, indicating fundamental business failure and potential bankruptcy risk.

What is GNRSU stock trading at now?

GNRSU trades at $0.000001 USD as of May 6, 2026, on the pink sheets (PNK) exchange. The market cap is just $13 with only 145 shares traded. This represents essentially zero value for shareholders.

Is GNRSU stock a buy at these prices?

GNRSU is extremely high-risk. Negative tangible assets of -$116.3 million and a current ratio of 0.21 suggest potential bankruptcy. Investors should seek professional financial advice before considering any position in this distressed security.

What does Meyka AI say about GNRSU?

Meyka AI rates GNRSU with a B grade and HOLD recommendation based on multiple factors including sector performance and financial metrics. However, these grades are not guaranteed and don’t reflect the company’s severe distress.

What is The Greenrose Holding Company?

Greenrose Holding Company Inc. is a healthcare sector cannabis producer based in Amityville, New York. Founded in 2014 and IPO’d in February 2020, it cultivates, processes, and packages medical cannabis products with 91 full-time employees.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)